Skip to content

Hikma Pharmaceuticals PLC Sustainability Reports

Hikma Pharmaceuticals PLC develops, manufactures, and markets a broad range of branded and generic pharmaceutical products. The company operates across three main segments: Injectables, Generics, and Branded products, serving markets in North America, MENA, and Europe.

Sector: Manufacturing

Country: United Kingdom

Exchange: London Stock Exchange

LEI: 549300BNS685UXH4JI75

FIGI: BBG001SNK879

35 reports from 2006 to 2026